42 articles, transcripts, and reports
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Ryan Crowe — Vice President of Investor Relations Leonard Schleifer — President & Chief…
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q1 2022 Earnings Conference
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q4 2021 earnings call dated Feb. 04, 2022 Corporate Participants: Mark Hudson — Director, Investor Relations Leonard S. Schleifer — Founder, President and Chief…
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q3 2021 Earnings Conference
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q2 2021 Earnings Conference
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q1 2021 earnings call dated May. 06, 2021 Corporate Participants: Justin Holko — Vice President, Investor Relations Leonard S. Schleifer — Co-Founder, President and…
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q1 2021 Earnings Conference
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Q4 2020 earnings call dated Feb. 05, 2021 Corporate Participants: Justin Holko — Vice President, Investor Relations Leonard S. Schleifer — Co-Founder, President and…
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported a 36% jump in earnings for the first quarter of 2020 helped by higher revenue. The results exceeded analysts’…
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2019 Earnings Conference Call Feb. 06, 2020 Corporate participants: Justin Holko — Investor Relations Leonard S. Schleifer — Founder,…
